2 top ETFs for ASX investors to buy in October

These ETFs could be top options for investors in October…

| More on:
ETF written in yellow with a yellow underline and the full word spelt out in white underneath.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're looking for an easy way to invest your hard-earned money, then exchange traded funds (ETFs) could be the answer.

That's because ETFs give you the opportunity to invest in a large group of shares in one fell swoop, which can be a great way to build a diverse portfolio.

But which ETFs should you look at this month? Here are two popular ETFs that could be quality options right now:

BetaShares NASDAQ 100 ETF (ASX: NDQ)

The BetaShares NASDAQ 100 ETF could be worth considering in October. Particularly given its incredibly poor showing during September, which has left it trading around its lowest levels of the year.

This ETF provides investors with access to the top 100 non-financial shares on the famous NASDAQ stock exchange. This includes the likes of Alphabet, Amazon, Apple, Meta, Microsoft, Netflix, Nvidia, and Tesla.

BetaShares also highlights that with a strong focus on technology, the ETF provides investors with diversified exposure to a high-growth potential sector that is under-represented on the Australian share market.

ETFS S&P Biotech ETF (ASX: CURE)

Another ETF for investors to consider in October is the ETFS S&P Biotech ETF.

This ETF gives investors exposure to the U.S. biotechnology sector. ETFS notes that these are companies that are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering. This includes the development of immunotherapy treatments and vaccines to treat human diseases.

Among its holdings you will find the likes of ChemoCentryx, Global Blood Therapeutics, and Twist Bioscience.

A big fan of the ETF is Felicity Thomas from Shaw & Partners. She recently told Livewire:

I like to buy ETFs for the long term. We have an ageing population, and what's the most important thing in the world? Your health. Biotech, healthcare, and life sciences, that's where you want to be invested over the next couple of decades.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended BETANASDAQ ETF UNITS and ETFS S&P Biotech ETF. The Motley Fool Australia has positions in and has recommended BETANASDAQ ETF UNITS. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ETFs

ETF spelt out with a rising green arrow.
ETFs

5 high-quality ASX ETFs to buy in August

Let's see what makes these funds top picks for Aussie investors.

Read more »

A businesswoman weighs up the stack of cash she receives, with the pile in one hand significantly more than the other hand.
ETFs

Does the VanEck Wide Moat ETF really have a 6% dividend yield right now?

How can an American-focused ETF pay such a big yield?

Read more »

Happy woman on her phone while her electric vehicle charges.
ETFs

EV demand comes roaring back. Time to buy this EV-focused ASX ETF?

Global EV demand has surged 30% year-on-year.

Read more »

A couple sit in their home looking at a phone screen as if discussing a financial matter.
ETFs

3 high-yield ASX ETFs to beat falling interest rates

Are you looking to boost passive income?

Read more »

A young man wearing glasses writes down his stock picks in his living room.
ETFs

4 reasons why this ASX ETF is one of the best buys today

I think this is one of the most exciting buys for Aussies.

Read more »

a business person checks his mobile phone outside a Wall Street office with an American flag and other business people in the background.
ETFs

S&P 500 reaches another all time high! Why MOAT ETF should outperform IVV ETF from here

Are you looking to invest in US-focused ASX ETFs? Read this first.

Read more »

The letters ETF with a man pointing at it.
ETFs

Invest $5,000 into these ASX ETFs in August

Let's see why these funds could be worth a spot in your portfolio.

Read more »

A smiling woman with a satisfied look on her face lies on a rug in her home with her laptop open and a large cup on the floor nearby, gazing at the screen. researching new ETFs
ETFs

Is the Vanguard Australian Shares High Yield ETF (VHY) unit price a buy for passive income?

The VHY ETF has a reputation for big dividends. Is it a buy today?

Read more »